1. Svartberg J et al. Waist circumference and testosterone levels in community dwelling men. Eur J Epidemiol 2004; 19: 657–63.
2. Grossmann M et al. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab 2011; 96 (8): 2341–53.
3. Zitzmann M et al. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006; 91: 4335–43.
4. Wang et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009; 12 (1): 5–12.
5. Cai X, Tian Y, Wu T et al. Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and metaanalysis of randomized controlled trials. Asian J Androl 2013.
6. Савельева Л.В., Роживанов Р.В., Шурдумова Б.О., Фадеев В.В. Нормогонадотропный гипогонадизм у мужчин с ожирением. Ожирение и метаболизм. 2009; 3.
7. Post Graduate International School of Men’s Health (PRISM) http://www.prismhealthonline.com
Авторы
По материалам Post Graduate International School of Men’s Health (Гент, Бельгия, 2014)
Е.А.Трошина
ФГБУ Эндокринологический научный центр Минздрава России